THOMAS MAJERNICK: Open Payments
NPI 1972583995 · OLYPHANT, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,222 in 22 payments from 11 companies in 2025. Trend: 2023 $652 · 2024 $458 · 2025 $1,222
Food & beverage: $1,222
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 2 | $291 |
| Lilly USA, LLC | 6 | $168 |
| Amgen Inc. | 4 | $143 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Actelion Pharmaceuticals US, Inc. | 1 | $122 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $120 |
| AstraZeneca Pharmaceuticals LP | 1 | $88 |
| Axsome Therapeutics, Inc. | 1 | $75 |
| ABBVIE INC. | 3 | $54 |
| PFIZER INC. | 1 | $20 |
Products named: SYMPLICITY G3, JARDIANCE, REPATHA, ZEPBOUND, VOQUEZNA, UPTRAVI, CATALYFT PL EXPANDABLE INTERBODY SYSTEM, AIRSUPRA.
Industry payments across PA — which companies pay providers there.
